Antagonists of toll like receptor 4 maybe a new strategy to counteract opioid-induced hyperalgesia and opioid tolerance

Medical Hypotheses

Volumn 79, Issue 6, 2012, Pages 754-756

  Li, Qian ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; MORPHINE; NALOXONE; NALTREXONE; OPIATE; TOLL LIKE RECEPTOR 4;

ARTICLE; CELL FUNCTION; DRUG EFFECT; DRUG MECHANISM; HUMAN; HYPERALGESIA; LOW DRUG DOSE; MICROGLIA; MORPHINE TOLERANCE; NONHUMAN; OPIOID INDUCED HYPERALGESIA; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION;

DRUG TOLERANCE; HUMANS; HYPERALGESIA; IMMUNITY, INNATE; MODELS, THEORETICAL; OPIOID PEPTIDES; TOLL-LIKE RECEPTOR 4;

EID: 84869087054     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.08.021     Document Type: Article

References (21)

1. Ahlbeck K. Opioids: a two-faced Janus. Curr Med Res Opin 2011, 27:439-448.
2. Horvath R.J., Romero-Sandoval E.A., De Leo J.A. Inhibition of microglial P2X4 receptors attenuates morphine tolerance, Iba1, GFAP and mu opioid receptor protein expression while enhancing perivascular microglial ED2. Pain 2010, 150:401-413.
3. Zhou D., Chen M.L., Zhang Y.Q., Zhao Z.Q. Involvement of spinal microglial P2X7 receptor in generation of tolerance to morphine analgesia in rats. J Neurosci 2010, 30:8042-8047.
4. Cui Y., Chen Y., Zhi J.L., Guo R.X., Feng J.Q., Chen P.X. Activation of p38 mitogen-activated protein kinase in spinal microglia mediates morphine antinociceptive tolerance. Brain Res 2006, 1069:235-243.
5. Cui Y., Liao X.X., Liu W., et al. A novel role of minocycline: attenuating morphine antinociceptive tolerance by inhibition of p38 MAPK in the activated spinal microglia. Brain Behav Immun 2008, 22:114-123.
6. Hutchinson M.R., Zhang Y., Brown K., et al. Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur J Neurosci 2008, 28:20-29.
7. Bettoni I., Comelli F., Rossini C., et al. Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia 2008, 56:1312-1319.
8. Tanga F.Y., Nutile-McMenemy N., DeLeo J.A. The CNS role of toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci USA 2005, 102:5856-5861.
9. Liu L., Coller J.K., Watkins L.R., Somogyi A.A., Hutchinson M.R. Naloxone-precipitated morphine withdrawal behavior and brain IL-1beta expression: comparison of different mouse strains. Brain Behav Immun 2011, 25:1223-1232.
10. Wu H.E., Hong J.S., Tseng L.F. Stereoselective action of (+)-morphine over (-)-morphine in attenuating the (-)-morphine-produced antinociception via the naloxone-sensitive sigma receptor in the mouse. Eur J Pharmacol 2007, 571:145-151.
11. Kelley K.W., Dantzer R. Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders. Brain Behav Immun 2011, 25(Suppl. 1):S13-S20.
12. Hutchinson M.R., Loram L.C., Zhang Y., et al. Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity. Neuroscience 2010, 168:551-563.
13. Hutchinson M.R., Lewis S.S., Coats B.D., et al. Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences. Neuroscience 2010, 167:880-893.
14. Hutchinson M.R., Zhang Y., Shridhar M., et al. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun 2010, 24:83-95.
15. Levine J.D., Gordon N.C., Fields H.L. Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain. Nature 1979, 278:740-741.
16. Liu B., Du L., Hong J.S. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther 2000, 293:607-617.
17. Chang R.C., Rota C., Glover R.E., Mason R.P., Hong J.S. A novel effect of an opioid receptor antagonist, naloxone, on the production of reactive oxygen species by microglia: a study by electron paramagnetic resonance spectroscopy. Brain Res 2000, 854:224-229.
18. Lu X., Bing G., Hagg T. Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats. Neuroscience 2000, 97:285-291.
19. Liu B., Du L., Kong L.Y., et al. Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures. Neuroscience 2000, 97:749-756.
20. Lin S.L., Tsai R.Y., Shen C.H., et al. Co-administration of ultra-low dose naloxone attenuates morphine tolerance in rats via attenuation of NMDA receptor neurotransmission and suppression of neuroinflammation in the spinal cords. Pharmacol Biochem Behav 2010, 96:236-245.
21. Hutchinson M.R., Bland S.T., Johnson K.W., Rice K.C., Maier S.F., Watkins L.R. Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. Sci World J 2007, 7:98-111.